Skip to main content

Advertisement

SpringerLink
Log in

NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism has been reported to influence the risk for esophageal cancer (EC) in many studies; however, the results remain controversial and ambiguous. We therefore carried out a meta-analysis of published case–control studies to investigate the association between NQO1 C609T polymorphism and EC susceptibility. Electronic searches were conducted on links between this variant and EC in several databases. Odds ratios (ORs) and 95 % confidence intervals (CIs) for homozygous, dominant model, recessive model and allele were calculated to estimate the strength of associations in fixed and random effect models. Heterogeneity and publication bias were also assessed. A total of 11 case–control studies were identified, including1,619 cases and 2,101 controls. C allele was associated with a decreased susceptibility risk of EC compared with the T allele among Chinese (OR = 0.70; 95 % CI = 0.59–0.84). The contrast of homozygotes and the recessive and dominant models produced the same pattern of results as the allele contrast. Our pooled data suggest a significant association exists between NQO1 C609T polymorphism and EC among Chinese.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241–52.

    Article  PubMed  CAS  Google Scholar 

  2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.

    Article  PubMed  CAS  Google Scholar 

  3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

    Article  PubMed  Google Scholar 

  4. Zhong S, Zhao W, Lu C, Li B, Yuan Y, Guo D, et al. Glutathione S-transferase M1 null genotype contributes to increased risk of esophageal carcinoma in Chinese population. Tumour Biol. 2013;34(4):2403–7.

    Article  PubMed  CAS  Google Scholar 

  5. Zhang J, Zhou J, Zhang P, Wang W, Tao S, Wang M. A meta-analysis of the association between the hOGG1 Ser326Cys polymorphism and the risk of esophageal squamous cell carcinoma. PLoS One. 2013;8(6):e65742.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  6. Jaiswal AK. Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Radic Biol Med. 2000;29(3–4):254–62.

    Article  PubMed  CAS  Google Scholar 

  7. Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, et al. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer. 1997;75:69–75.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  8. Kuehl BL, Paterson JW, Peacock JW, Paterson MC, Rauth AM. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer. 1995;72:555–61.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  9. Sarbia M, Bitzer M, Siegel D, Ross D, Schulz WA, Zotz RB, et al. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. Int J Cancer. 2003;107(3):381–6.

    Article  PubMed  CAS  Google Scholar 

  10. Umar M, Upadhyay R, Kumar S, Ghoshal UC, Mittal B. Null association of NQO1 609C>T and NQO2–3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis. Cancer Epidemiol. 2012;36(6):e373–9.

    Article  PubMed  CAS  Google Scholar 

  11. Yanling H, Yuhong Z, Wenwu H, Lei X, Mingwu C. NQO1 C609T polymorphism and esophageal cancer risk: a HuGE review and meta-analysis. BMC Medical Genetics. 2013;14:31.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  12. Berlin JA, Laird NM, Sacks HS, Chalmers TC. A comparison of statistical methods for combining event rates from clinical trials. Stat Med. 1989;8(2):141–51.

    Article  PubMed  CAS  Google Scholar 

  13. Poole C, Greenland S. Random-effects meta-analyses are not always conservative. Am J Epidemiol. 1999;150:469–75.

    Article  PubMed  CAS  Google Scholar 

  14. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    PubMed  CAS  Google Scholar 

  15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    Article  PubMed  CAS  Google Scholar 

  16. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.

    Article  Google Scholar 

  17. di Martino E, Hardie LJ, Wild CP, Gong YY, Olliver JR, Gough MD, et al. The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma. Genet Med. 2007;9(6):341–7.

    Article  PubMed  CAS  Google Scholar 

  18. Feng XX, Li ZF, Wang LB, Zhang JB, Lu ZX. Study on the relationship between polymorphisms of NQO1 gene and susceptibility to esophageal cancer. Chin J Dis Control Prev. 2008;12(2):112–4.

    CAS  Google Scholar 

  19. Hamajima N, Matsuo K, Iwata H, Shinoda M, Yamamura Y, Kato T, et al. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol. 2002;7(2):103–8.

    PubMed  CAS  Google Scholar 

  20. Malik MA, Zargar SA, Mittal B. Role of NQO1 609C>T and NQO2–3423G>A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysis. Mol Biol Rep. 2012;39(9):9095–104.

    Article  PubMed  CAS  Google Scholar 

  21. Marjani HA, Biramijamal F, Rakhshani N, Hossein-Nezhad A, Malekzadeh R. Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case–control study from Iran. Genet Mol Res. 2010;9(1):239–49.

    Article  PubMed  CAS  Google Scholar 

  22. von Rahden BH, Stein HJ, Langer R, von Weyhern CW, Schenk E, Döring C, et al. C609T polymorphism of the NAD(P)H:quinone oxidoreductase I gene does not significantly affect susceptibility for esophageal adenocarcinoma. Int J Cancer. 2005;113(3):506–8.

    Article  CAS  Google Scholar 

  23. Zhang J, Schulz WA, Li Y, Wang R, Zotz R, Wen D, et al. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Carcinogenesis. 2003;24(5):905–9.

    Article  PubMed  CAS  Google Scholar 

  24. Zhang JH, Li Y, Wang R, Geddert H, Guo W, Wen DG, et al. NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World J Gastroenterol. 2003;9(7):1390–3.

    PubMed  CAS  Google Scholar 

  25. Zhang WC, Yin LH, Pu YP, Liang GY, Hu X, Liu YZ, et al. Relationship between quinone oxidoreductase 1 gene ns-SNP and genetic susceptibility of esophageal cancer. Chin J Prev Med. 2006;40:324–7.

    CAS  Google Scholar 

  26. Zhou YL, Chen HF, Shi XS, Zhou ZJ, Li GL, Pan PC, et al. A case–control study on the polymorphisms of NQO1 and susceptibility of esophageal cancer. Chin Cancer. 2006;15:659–63.

    CAS  Google Scholar 

  27. Kelsey KT, Ross D, Traver RD, Christiani DC, Zuo ZF, Spitz MR, et al. Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br J Cancer. 1997;76:852–4.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Central Laboratory, The Second Affiliated Hospital of Southeast University, 210003, Nanjing, People’s Republic of China

    Hong-Yu Zhao

  2. Department of Oncology, The Second Affiliated Hospital of Southeast University, 210003, Nanjing, People’s Republic of China

    Yan Gu

  3. Department of Surgery, The Second Affiliated Hospital of Southeast University, 1-1 Zhongfu Street, 210003, Nanjing, Jiangsu, People’s Republic of China

    Yong-Xiang Yi

Authors
  1. Hong-Yu Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yan Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yong-Xiang Yi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yong-Xiang Yi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, HY., Gu, Y. & Yi, YX. NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysis. Tumor Biol. 35, 2199–2203 (2014). https://doi.org/10.1007/s13277-013-1292-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1292-z

Keywords

Search

Navigation